Bioleap, Inc.
USPTO PatentsView assignee record - 6 granted patents across 9 technology areas, recorded in grant years 2018–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01D (Separation).
The verdict
According to USPTO PatentsView, Bioleap ranks #39,122 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 9 technology areas.
- #39,122
- of 49,997 US assignees by volume
- 17th percentile
- by Innovation Score (25.4/100)
- 13.5
- avg claims per patent
- -50%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R39122 · US Corporation #39,122 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 6 grants
- LOWER-Q #39,122/49,997
- PHOTO-FINISH Biocoat Incorporated
- CPC-NARROW B01D · 9 areas
- INNOV-THIN 25.4/100
- CLAIMS-RICH 13.5 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -50% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Biocoat, Incorporated (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Bioleap’s 25.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Bioleap
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Bioleap · this assignee 25
Bioleap · this assignee
25 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Bioleap's Innovation Score is 25.4/100 (17th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Bioleap?
Each dot is one of Bioleap’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bioleap’s own 13.5 claims/patent is ABOVE the 12.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Bioleap's grants concentrate
Bioleap, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under B01D (Separation). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2018. By volume, Bioleap sits between BioGenware, LLC and Biomineral Systems LLC.
Who files at Bioleap's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Biogenware
BioGenware, LLC
6 patents
- Bioreference Heal…
BioReference Health, LLC
6 patents
- Biospecifics
BioSpecifics Technologies LLC
6 patents
- Biocoat Incorpora…
Biocoat, Incorporated
6 patents
- Biolumic
Biolumic Limited
6 patents
- Biomass Energy En…
Biomass Energy Enhancements, LLC
6 patents
- Biomilk
Biomilk Ltd.
6 patents
- Biomineral Systems
Biomineral Systems LLC
6 patents
- Bioleap ◀
Bioleap, Inc.
6 patents
What this shows Bioleap holds 6 patents at rank #39,204, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Bioleap
By rank, the assignees closest to #39,204 in granted patent volume.
- BioGenware, LLC #39,200 · 6 patents
- BioReference Health, LLC #39,201 · 6 patents
- BioSpecifics Technologies LLC #39,202 · 6 patents
- Biocoat, Incorporated #39,203 · 6 patents
- Biolumic Limited #39,205 · 6 patents
- Biomass Energy Enhancements, LLC #39,206 · 6 patents
- Biomilk Ltd. #39,207 · 6 patents
- Biomineral Systems LLC #39,208 · 6 patents
Leaders in B01D (Separation)
Other assignees with the most granted patents in Bioleap's primary technology class.
Bioleap's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
25 17th percentile higher than 17% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 16.7% |
| 2019 | 3 | 50.0% |
| 2020 | 2 | 33.3% |
Which technologies does Bioleap, Inc. patent most?
Top 9 of 9 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Bioleap, Inc.'s patent record in context - here's where to go next.
- Bioleap, Inc.'s lead technology class is B01D (Separation), 100% of its portfolio - see every assignee active in that class. Explore B01D
- Ranked #39,122 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Bioleap, Inc. against BioGenware, LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 25.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.